Stalevo: Clinical Trials

3 trials of Stalevo, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3

Follow Stalevo: new trials by email Literature Review of Stalevo trials Research Report on Stalevo

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
Stalevo, levodopa MR - Parkinson's Disease
Phase 2CompletedOrion Corporation, Orion Pharma842016-04-082018-04-05
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations
ODM-101 65mg Carbidopa, ODM-101 105mg Carbidopa, Stalevo - Parkinson's Disease
Phase 2CompletedOrion Corporation, Orion Pharma1172011-05-012013-11-21
An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
carbidopa/l-dopa, carbidopa/l-dopa/entacapone, Stalevo - Parkinson's Disease
Phase 2CompletedMolecular NeuroImaging32004-03-012008-01-21

Conditions studied

Parkinson Disease (3)

Sponsors

Orion Corporation, Orion Pharma (2)  ·  Molecular NeuroImaging (1)

Countries

Finland (1)  ·  Germany (1)  ·  Hungary (1)  ·  Latvia (1)

Top investigators

Aila Holopainen, MSc (1)  ·  Claudia Trenkwalder, MD (1)  ·  John P Seibyl, MD (1)

Results publications

PMID 30824559